Q (haiku): What percentage of endometrial cancer patients have co-occurring oncogenic mutations in both KRAS and NRAS?

▶ read_guide
{
 "uri": "cbioportal://mutation-frequency-guide"
}

▶ read_guide
{
 "uri": "cbioportal://common-pitfalls#16"
}

◀ result
# Mutation Frequency Analysis Guide

## IMPORTANT: Reporting Mutation Frequencies
- **ALWAYS report frequencies as percentages**, not raw counts: `frequency = (altered_samples / total_profiled_samples) × 100`
- For quick frequency lookups, **prefer the TCGA Pan-Cancer Atlas study first**, then offer to expand to other studies
- When reporting across multiple studies, show **ranges** (e.g., "TP53 is mutated in 30–60% of samples") rather than a single average
- **NEVER** sum mutation events across studies to compute an aggregate frequency — this can exceed 100% due to double-counting
- Warn users that samples may overlap across cohorts (e.g., MSK studies may share patients)
- **Choose and state the counting unit**: use patient-level frequencies for prevalence/rate questions unless the user explicitly asks for samples; use sample-level frequencies when the user asks about samples.
- **For "across cancer types" questions**, jump to the [Cross-Cancer-Type Mutation Frequency](#cross-cancer-type-mutation-frequency) section below — there is one correct recipe and several common wrong ones.

## Counting Unit: Samples vs Patients

Before answering any mutation count or frequency question, decide whether the unit is samples or patients and state that choice in the answer.

| User wording | Counting unit |
|--------------|---------------|
| "prevalence", "rate", "fraction of patients", "patients with", "how common is" | Patient-level: `COUNT(DISTINCT patient_unique_id)` |
| "samples", "specimens", "biopsies", sample-level cohort composition | Sample-level: `COUNT(DISTINCT sample_unique_id)` |
| Ambiguous | Ask, or default to patient-level for prevalence/rate language and say so |

### Cross-study sample-count caveat

When an answer touches more than one study and reports a sample count, prepend a one-line caveat:

> Sample IDs are unique within cBioPortal study prefixes, not guaranteed biological-sample identifiers across studies; overlapping cohorts can count the same patient/sample more than once.

Prefer one of these safer approaches:

- Use a shipped `cancer_study_query_preferences` cohort such as `pan_cancer_tcga` or `all_studies_non_redundant`.
- Restrict to one named study.
- Aggregate by `patient_unique_id` when the biological question is patient prevalence.

## STOP rule: a frequency above 100% means your query is wrong

If your query returns a frequency over 100%, **do not try to debug or explain the data inconsistency to the user**. The cause is always one of these query bugs:

- Summing mutation events instead of `COUNT(DISTINCT sample_unique_id)` for the numerator
- Using a study-wide sample count as the denominator instead of the gene-specific profiled count
- Cross-study aggregation where the same biological sample appears under multiple `sample_unique_id` values (e.g., MSK-IMPACT and MSK-CHORD share patients)
- **Joining the profiled CTE through `gene_panel` / `gene_panel_list` without a WES branch.** `gene_panel_id = 'WES'` is *not* a row in … (35166 more chars)

◀ result
### 16. 🚨 SILENT QUERY SUBSTITUTION ("did you mean...")

When the user's wording differs from canonical terminology (e.g. "V600V" looks like "V600E" with a typo, or "point mutation" sounds like "missense"), it is forbidden to silently rewrite the question and answer the rewritten version. Doing so produces an answer that looks confident but is for a different question — the user cannot tell what was changed.

#### ❌ Wrong: silently substitute

> User: *"Find patients in colorectal cancer with the V600V alteration in BRAF"*
> Agent: *(internally treats this as V600E)* "I found 412 samples with BRAF V600E in colorectal studies..."

> User: *"What is the most prevalent TP53 mutation in uterine cancer that is not a point mutation?"*
> Agent: *(internally treats "point mutation" = "missense", silently excludes only missense)* "The most prevalent non-missense TP53 mutation is..."

#### ✅ Correct: answer the literal question, flag any normalization

For an unusual-looking variant the user may have typed deliberately:
- Query for what was asked, literally.
- If 0 rows come back, **explain *why* zero is the expected answer** before suggesting a likely-intended alternative. For synonymous variants (e.g. BRAF V600V, TP53 R175R), the explanation is: *cBioPortal's mutation tables filter out synonymous (silent) variants in most studies, so 0 hits means "filtered upstream", not "no such variant exists in any patient"*. Then ask: *"Did you mean V600E (the canonical activating variant)? Or would you like me to look for V600V in the studies that do retain synonymous calls?"*
- If the wording is ambiguous (e.g. "point mutation"), ask the user which definition they meant before querying — do not pick one silently.

#### Mutation-type terminology mapping (use this to disambiguate)

| User says | Canonical definition | `mutation_type` filter |
|---|---|---|
| "point mutation" | Any SNV (single-nucleotide variant) — includes missense, nonsense, synonymous, splice-site SNVs | `mutation_type IN ('Missense_Mutation','Nonsense_Mutation','Silent','Splice_Site')` — **but ask the user to confirm scope first** |
| "missense" | Single amino-acid substitution that changes the protein | `mutation_type = 'Missense_Mutation'` |
| "nonsense" / "stop-gain" | Premature stop codon | `mutation_type = 'Nonsense_Mutation'` |
| "synonymous" / "silent" | Nucleotide change with no amino-acid change | `mutation_type = 'Silent'` (**often filtered out of public datasets** — see below) |
| "splice site" | Mutation in canonical splice acceptor/donor | `mutation_type = 'Splice_Site'` |
| "frameshift" | Indel changing reading frame | `mutation_type IN ('Frame_Shift_Ins','Frame_Shift_Del')` |
| "indel" / "in-frame" | In-frame insertion or deletion | `mutation_type IN ('In_Frame_Ins','In_Frame_Del')` |
| "truncating" | Anything that disrupts the protein early | `mutation_type IN ('Nonsense_Mutation','Frame_Shift_Ins','Frame_Shift_Del','Splice_Site','Nonstop_Mutation')` |

**Synonymous-variant filter. … (785 more chars)

▶ resolve_and_route
{
 "studyKeywords": [
  "endometrial"
 ]
}

▶ search_oncotree
{
 "search_term": "endometrial"
}

◀ result
{"success":true,"message":"Found 14 matching studies (top 5 with full metadata, rest with basic info). Pick the best match (prefer TCGA → prefer PanCancer Atlas), use its metadata to call the appropriate navigation tool(s) and generate URLs immediately. Present other studies as alternatives.","data":{"totalCount":14,"studiesWithMetadata":[{"studyId":"ucec_ancestry_cds_msk_2023","name":"Endometrial Cancer (MSK, Cancer Discovery 2023)","sampleCount":1882,"studyViewUrl":"https://www.cbioportal.org/study?id=ucec_ancestry_cds_msk_2023","metadata":{"clinicalAttributeIds":["CANCER_TYPE","CANCER_TYPE_DETAILED","ETHNICITY","GENE_PANEL","HISTOLOGY","MOLECULAR_SUBTYPE","MUTATION_COUNT","ONCOTREE_CODE","RACE","SAMPLE_COUNT","SAMPLE_TYPE","SOMATIC_STATUS","TMB_NONSYNONYMOUS"],"molecularProfileIds":["ucec_ancestry_cds_msk_2023_cna","ucec_ancestry_cds_msk_2023_mutations"],"availableComparisonTabs":["overlap","clinical","alterations","mutations"]}},{"studyId":"ucec_tcga","name":"Uterine Corpus Endometrial Carcinoma (TCGA, Firehose Legacy)","sampleCount":549,"studyViewUrl":"https://www.cbioportal.org/study?id=ucec_tcga","metadata":{"clinicalAttributeIds":["AGE","AJCC_PATHOLOGIC_TUMOR_STAGE","AJCC_STAGING_EDITION","CANCER_TYPE","CANCER_TYPE_DETAILED","CLINICAL_STAGE","CLIN_M_STAGE","CLIN_N_STAGE","CLIN_T_STAGE","DAYS_TO_COLLECTION","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","DAYS_TO_SPECIMEN_COLLECTION","DFS_MONTHS","DFS_STATUS","DIABETES_DIAGNOSIS_INDICATOR","DISEASE_CODE","ETHNICITY","EXTRANODAL_INVOLVEMENT","FORM_COMPLETION_DATE","FRACTION_GENOME_ALTERED","GRADE","HEIGHT","HISTOLOGICAL_DIAGNOSIS","HISTORY_COLORECTAL_CANCER","HISTORY_HORMONAL_CONTRACEPTIVES_USE","HISTORY_MENOPAUSAL_HORMONE_THERAPY","HISTORY_NEOADJUVANT_TRTYN","HISTORY_OTHER_MALIGNANCY","HISTORY_TAMOXIFEN_USE","HYPERTENSION_DIAGNOSIS","ICD_10","ICD_O_3_HISTOLOGY","ICD_O_3_SITE","INFORMED_CONSENT_VERIFIED","INITIAL_PATHOLOGIC_DX_YEAR","IS_FFPE","LONGEST_DIMENSION","LYMPH_NODES_AORTIC_EXAMINED_COUNT","LYMPH_NODES_AORTIC_POS_BY_HE","LYMPH_NODES_AORTIC_POS_BY_IHC","LYMPH_NODES_AORTIC_POS_TOTAL","LYMPH_NODES_PELVIC_EXAMINED_COUNT","LYMPH_NODES_PELVIC_POS_BY_HE","LYMPH_NODES_PELVIC_POS_BY_IHC","LYMPH_NODES_PELVIC_POS_TOTAL","MENOPAUSE_STATUS","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","METHOD_OF_SAMPLE_PROCUREMENT","MUTATION_COUNT","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","OCT_EMBEDDED","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","OTHER_PATIENT_ID","OTHER_SAMPLE_ID","PATHOLOGY_REPORT_FILE_NAME","PATHOLOGY_REPORT_UUID","PATH_M_STAGE","PATH_N_STAGE","PATH_T_STAGE","PERITONEAL_WASHING","PHARMACEUTICAL_TX_ADJUVANT","PREGNANCIES_FULL_TERM_COUNT","PRIMARY_SITE_OTHER","PROJECT_CODE","PROSPECTIVE_COLLECTION","RACE","RADIATION_TREATMENT_ADJUVANT","RESIDUAL_TUMOR","RETROSPECTIVE_COLLECTION","SAMPLE_COUNT","SAMPLE_INITIAL_WEIGHT","SAMPLE_TYPE","SAMPLE_TYPE_ID","SEX","SHORTEST_DIMENSION","SITE_OF_TUMOR_TISSUE","SOMATIC_STATUS","SPECIMEN_CURRENT … (8930 more chars)

◀ result
{"result":[{"code":"ESS","name":"Endometrial Stromal Sarcoma","score":60,"mainType":"Uterine Sarcoma","tissue":"Uterus","hierarchy":"UTERUS > USARC > ESS"},{"code":"UCEC","name":"Endometrial Carcinoma","score":60,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC"},{"code":"HGESS","name":"High-Grade Endometrial Stromal Sarcoma","score":50,"mainType":"Uterine Sarcoma","tissue":"Uterus","hierarchy":"UTERUS > USARC > ESS > HGESS"},{"code":"LGESS","name":"Low-Grade Endometrial Stromal Sarcoma","score":50,"mainType":"Uterine Sarcoma","tissue":"Uterus","hierarchy":"UTERUS > USARC > ESS > LGESS"},{"code":"UMEC","name":"Uterine Mixed Endometrial Carcinoma","score":50,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UMEC"},{"code":"OUTT","name":"Other Uterine Tumor","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > OUTT"},{"code":"UASC","name":"Uterine Adenosquamous Carcinoma","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UASC"},{"code":"UCCC","name":"Uterine Clear Cell Carcinoma","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UCCC"},{"code":"UCS","name":"Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UCS"},{"code":"UDDC","name":"Uterine Dedifferentiated Carcinoma","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UDDC"},{"code":"UEC","name":"Uterine Endometrioid Carcinoma","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UEC"},{"code":"UMC","name":"Uterine Mucinous Carcinoma","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UMC"},{"code":"UMNC","name":"Uterine Mesonephric Carcinoma","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UMNC"},{"code":"UNEC","name":"Uterine Neuroendocrine Carcinoma","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UNEC"},{"code":"UPDC","name":"Poorly Differentiated Carcinoma of the Uterus","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UPDC"},{"code":"USC","name":"Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > USC"},{"code":"UUC","name":"Uterine Undifferentiated Carcinoma","score":45,"mainType":"Endometrial Cancer","tissue":"Uterus","hierarchy":"UTERUS > UCEC > UUC"}]}

▶ clickhouse_run_select_query
{
 "query": "
-- Co-occurring KRAS and NRAS mutations in endometrial cancer (TCGA PanCancer Atlas)
-- Patient-level frequency: patients with both KRAS and NRAS mutations / all profiled patients

WITH kras_mutants AS (
    SELECT DISTINCT patient_unique_id, sample_unique_id
    FROM genomic_event_derived
    WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
      AND hugo_gene_symbol = 'KRAS'
      AND variant_type = 'mutation'
      AND mutation_status != 'UNCALLED'
),
nras_mutants AS (
    SELECT DISTINCT patient_unique_id, sample_unique_id
    FROM genomic_event_derived
    WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
      AND hugo_gene_symbol = 'NRAS'
      AND variant_type = 'mutation'
      AND mutation_status != 'UNCALLED'
),
both_mutant_patients AS (
    SELECT DISTINCT k.patient_unique_id
    FROM kras_mutants k
    JOIN nras_mutants n ON k.patient_unique_id = n.patient_unique_id
),
profiled_for_both_genes AS (
    -- Get patients profiled for both KRAS and NRAS mutations
    SELECT DISTINCT p.patient_unique_id
    FROM (
        SELECT DISTINCT patient_unique_id
        FROM genomic_event_derived
        WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
          AND hugo_gene_symbol = 'KRAS'
    ) k
    CROSS JOIN (
        SELECT DISTINCT patient_unique_id
        FROM genomic_event_derived
        WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
          AND hugo_gene_symbol = 'NRAS'
    ) n
    JOIN (
        SELECT DISTINCT patient_unique_id
        FROM clinical_data_derived
        WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
    ) p USING (patient_unique_id)
)
SELECT
    (SELECT COUNT(DISTINCT patient_unique_id) FROM profiled_for_both_genes) AS total_profiled_patients,
    (SELECT COUNT(*) FROM both_mutant_patients) AS patients_with_both_kras_and_nras_mutations,
    ROUND(
        (SELECT COUNT(*) FROM both_mutant_patients) * 100.0 /
        NULLIF((SELECT COUNT(DISTINCT patient_unique_id) FROM profiled_for_both_genes), 0),
        1
    ) AS percentage_with_both_mutations;
",
 "max_rows": 10
}

◀ result
{"error_message":"Query execution failed: HTTPDriver for https://dl96orhu96.us-east-1.aws.clickhouse.cloud:8443 received ClickHouse error code 207\n Code: 207. DB::Exception: JOIN  CROSS JOIN ... ambiguous identifier 'patient_unique_id'. In scope  profiled_for_both_genes. (AMBIGUOUS_IDENTIFIER) (version 26.4.1.2359 (official build))\n"}

▶ clickhouse_run_select_query
{
 "query": "
-- Co-occurring KRAS and NRAS mutations in endometrial cancer (TCGA PanCancer Atlas)
-- Patient-level: patients with both mutations / all profiled patients

WITH kras_patients AS (
    SELECT DISTINCT patient_unique_id
    FROM genomic_event_derived
    WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
      AND hugo_gene_symbol = 'KRAS'
      AND variant_type = 'mutation'
      AND mutation_status != 'UNCALLED'
),
nras_patients AS (
    SELECT DISTINCT patient_unique_id
    FROM genomic_event_derived
    WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
      AND hugo_gene_symbol = 'NRAS'
      AND variant_type = 'mutation'
      AND mutation_status != 'UNCALLED'
),
both_mutant AS (
    SELECT COUNT(*) AS count_both
    FROM kras_patients k
    INNER JOIN nras_patients n USING (patient_unique_id)
),
all_profiled AS (
    SELECT COUNT(DISTINCT patient_unique_id) AS total_profiled
    FROM clinical_data_derived
    WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
)
SELECT
    ap.total_profiled,
    bm.count_both,
    ROUND(bm.count_both * 100.0 / ap.total_profiled, 1) AS pct_with_both
FROM all_profiled ap
CROSS JOIN both_mutant bm;
",
 "max_rows": 10
}

◀ result
{"rows":[{"total_profiled":529,"count_both":4,"pct_with_both":0.8}]}

▶ clickhouse_run_select_query
{
 "query": "
-- Individual KRAS and NRAS mutation frequencies in endometrial cancer (TCGA PanCancer Atlas)

WITH kras_patients AS (
    SELECT DISTINCT patient_unique_id
    FROM genomic_event_derived
    WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
      AND hugo_gene_symbol = 'KRAS'
      AND variant_type = 'mutation'
      AND mutation_status != 'UNCALLED'
),
nras_patients AS (
    SELECT DISTINCT patient_unique_id
    FROM genomic_event_derived
    WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
      AND hugo_gene_symbol = 'NRAS'
      AND variant_type = 'mutation'
      AND mutation_status != 'UNCALLED'
),
all_profiled AS (
    SELECT COUNT(DISTINCT patient_unique_id) AS total_profiled
    FROM clinical_data_derived
    WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
)
SELECT
    'KRAS' AS gene,
    (SELECT COUNT(*) FROM kras_patients) AS mutant_patients,
    ap.total_profiled,
    ROUND((SELECT COUNT(*) FROM kras_patients) * 100.0 / ap.total_profiled, 1) AS mutation_pct
FROM all_profiled ap
UNION ALL
SELECT
    'NRAS' AS gene,
    (SELECT COUNT(*) FROM nras_patients) AS mutant_patients,
    ap.total_profiled,
    ROUND((SELECT COUNT(*) FROM nras_patients) * 100.0 / ap.total_profiled, 1) AS mutation_pct
FROM all_profiled ap;
",
 "max_rows": 10
}

◀ result
{"rows":[{"gene":"KRAS","mutant_patients":99,"total_profiled":529,"mutation_pct":18.7},{"gene":"NRAS","mutant_patients":21,"total_profiled":529,"mutation_pct":4}]}

▶ clickhouse_run_select_query
{
 "query": "
-- Details of patients with co-occurring KRAS and NRAS mutations

WITH kras_data AS (
    SELECT DISTINCT
        patient_unique_id,
        'KRAS' AS gene,
        hugo_gene_symbol,
        mutation_variant,
        mutation_type
    FROM genomic_event_derived
    WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
      AND hugo_gene_symbol = 'KRAS'
      AND variant_type = 'mutation'
      AND mutation_status != 'UNCALLED'
),
nras_data AS (
    SELECT DISTINCT
        patient_unique_id,
        'NRAS' AS gene,
        hugo_gene_symbol,
        mutation_variant,
        mutation_type
    FROM genomic_event_derived
    WHERE cancer_study_identifier = 'ucec_tcga_pan_can_atlas_2018'
      AND hugo_gene_symbol = 'NRAS'
      AND variant_type = 'mutation'
      AND mutation_status != 'UNCALLED'
),
both_genes AS (
    SELECT DISTINCT k.patient_unique_id
    FROM kras_data k
    JOIN nras_data n USING (patient_unique_id)
)
SELECT
    COALESCE(k.patient_unique_id, n.patient_unique_id) AS patient_id,
    k.mutation_variant AS kras_variant,
    k.mutation_type AS kras_type,
    n.mutation_variant AS nras_variant,
    n.mutation_type AS nras_type
FROM (SELECT * FROM kras_data WHERE patient_unique_id IN (SELECT patient_unique_id FROM both_genes)) k
FULL OUTER JOIN (SELECT * FROM nras_data WHERE patient_unique_id IN (SELECT patient_unique_id FROM both_genes)) n
    ON k.patient_unique_id = n.patient_unique_id
ORDER BY COALESCE(k.patient_unique_id, n.patient_unique_id);
",
 "max_rows": 10
}

◀ result
{"rows":[{"patient_id":"ucec_tcga_pan_can_atlas_2018_TCGA-A5-A0G2","kras_variant":"Q61H","kras_type":"Missense_Mutation","nras_variant":"D47N","nras_type":"Missense_Mutation"},{"patient_id":"ucec_tcga_pan_can_atlas_2018_TCGA-A5-A0G2","kras_variant":"Q61H","kras_type":"Missense_Mutation","nras_variant":"F78S","nras_type":"Missense_Mutation"},{"patient_id":"ucec_tcga_pan_can_atlas_2018_TCGA-AX-A0J0","kras_variant":"K176Q","kras_type":"Missense_Mutation","nras_variant":"E162*","nras_type":"Nonsense_Mutation"},{"patient_id":"ucec_tcga_pan_can_atlas_2018_TCGA-B5-A0JV","kras_variant":"G12D","kras_type":"Missense_Mutation","nras_variant":"Q61K","nras_type":"Missense_Mutation"},{"patient_id":"ucec_tcga_pan_can_atlas_2018_TCGA-DF-A2KZ","kras_variant":"A146V","kras_type":"Missense_Mutation","nras_variant":"Q61R","nras_type":"Missense_Mutation"}]}

▶ resolve_and_route
{
 "studyIds": [
  "ucec_tcga_pan_can_atlas_2018"
 ]
}

◀ result
{"success":true,"message":"Found 1 study. Use the metadata to call the appropriate navigation tool(s).","data":{"totalCount":1,"studiesWithMetadata":[{"studyId":"ucec_tcga_pan_can_atlas_2018","name":"Uterine Corpus Endometrial Carcinoma (TCGA, PanCancer Atlas)","sampleCount":529,"studyViewUrl":"https://www.cbioportal.org/study?id=ucec_tcga_pan_can_atlas_2018","metadata":{"clinicalAttributeIds":["AGE","AJCC_PATHOLOGIC_TUMOR_STAGE","AJCC_STAGING_EDITION","ANEUPLOIDY_SCORE","BUFFA_HYPOXIA_SCORE","CANCER_TYPE","CANCER_TYPE_ACRONYM","CANCER_TYPE_DETAILED","DAYS_LAST_FOLLOWUP","DAYS_TO_BIRTH","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","DFS_MONTHS","DFS_STATUS","DSS_MONTHS","DSS_STATUS","ETHNICITY","FORM_COMPLETION_DATE","FRACTION_GENOME_ALTERED","GENETIC_ANCESTRY_LABEL","GRADE","HISTORY_NEOADJUVANT_TRTYN","ICD_10","ICD_O_3_HISTOLOGY","ICD_O_3_SITE","INFORMED_CONSENT_VERIFIED","IN_PANCANPATHWAYS_FREEZE","MSI_SCORE_MANTIS","MSI_SENSOR_SCORE","MUTATION_COUNT","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","OTHER_PATIENT_ID","PATH_M_STAGE","PATH_N_STAGE","PATH_T_STAGE","PERSON_NEOPLASM_CANCER_STATUS","PFS_MONTHS","PFS_STATUS","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","PRIOR_DX","RACE","RADIATION_THERAPY","RAGNUM_HYPOXIA_SCORE","SAMPLE_COUNT","SAMPLE_TYPE","SEX","SOMATIC_STATUS","SUBTYPE","TBL_SCORE","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","TISSUE_SOURCE_SITE","TISSUE_SOURCE_SITE_CODE","TMB_NONSYNONYMOUS","TUMOR_TISSUE_SITE","TUMOR_TYPE","WEIGHT","WINTER_HYPOXIA_SCORE"],"molecularProfileIds":["ucec_tcga_pan_can_atlas_2018_gistic","ucec_tcga_pan_can_atlas_2018_log2CNA","ucec_tcga_pan_can_atlas_2018_mutations","ucec_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","ucec_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","ucec_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_all_sample_Zscores","ucec_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_all_sample_ref_normal_Zscores","ucec_tcga_pan_can_atlas_2018_rppa","ucec_tcga_pan_can_atlas_2018_rppa_Zscores","ucec_tcga_pan_can_atlas_2018_structural_variants"],"genericAssayProfiles":["ucec_tcga_pan_can_atlas_2018_armlevel_cna","ucec_tcga_pan_can_atlas_2018_genetic_ancestry","ucec_tcga_pan_can_atlas_2018_methylation_hm27_hm450_merge","ucec_tcga_pan_can_atlas_2018_methylation_hm450"],"heatmapProfileIds":["ucec_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","ucec_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_all_sample_Zscores","ucec_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_all_sample_ref_normal_Zscores","ucec_tcga_pan_can_atlas_2018_rppa_Zscores"],"availableComparisonTabs":["overlap","clinical","survival","alterations","mutations","mrna","protein","generic_assay_armlevel_cna","generic_assay_genetic_ancestry","generic_assay_methylation"]}}]}}

▶ navigate_to_study_view
{
 "studyIds": [
  "ucec_tcga_pan_can_atlas_2018"
 ],
 "filterJson": {
  "geneFilters": [
   {
    "molecularProfileIds": [
     "ucec_tcga_pan_can_atlas_2018_mutations"
    ],
    "geneQueries": [
     [
      {
       "hugoGeneSymbol": "KRAS"
      },
      {
       "hugoGeneSymbol": "NRAS"
      }
     ]
    ]
   }
  ]
 },
 "tab": "summary"
}

◀ result
{"success":true,"message":"Navigating to https://www.cbioportal.org/study/summary?id=ucec_tcga_pan_can_atlas_2018#filterJson=%7B%22geneFilters%22%3A%5B%7B%22geneQueries%22%3A%5B%5B%7B%22hugoGeneSymbol%22%3A%22KRAS%22%7D%2C%7B%22hugoGeneSymbol%22%3A%22NRAS%22%7D%5D%5D%2C%22molecularProfileIds%22%3A%5B%22ucec_tcga_pan_can_atlas_2018_mutations%22%5D%7D%5D%7D","url":"https://www.cbioportal.org/study/summary?id=ucec_tcga_pan_can_atlas_2018#filterJson=%7B%22geneFilters%22%3A%5B%7B%22geneQueries%22%3A%5B%5B%7B%22hugoGeneSymbol%22%3A%22KRAS%22%7D%2C%7B%22hugoGeneSymbol%22%3A%22NRAS%22%7D%5D%5D%2C%22molecularProfileIds%22%3A%5B%22ucec_tcga_pan_can_atlas_2018_mutations%22%5D%7D%5D%7D","data":{"studyIds":["ucec_tcga_pan_can_atlas_2018"],"studies":[{"studyId":"ucec_tcga_pan_can_atlas_2018","name":"Uterine Corpus Endometrial Carcinoma (TCGA, PanCancer Atlas)","sampleCount":529}],"tab":"summary","hasFilters":true,"hasPlotsConfig":false,"pageDescription":"Overview of all study data displayed as interactive charts summarizing available clinical and genomic data. Click within a chart to filter. Additional charts may be available in the Charts menu."}}

▶ navigate_to_results_view
{
 "studyIds": [
  "ucec_tcga_pan_can_atlas_2018"
 ],
 "genes": [
  "KRAS",
  "NRAS"
 ],
 "tab": "mutations"
}

◀ result
{"success":true,"message":"Navigating to https://www.cbioportal.org/results/mutations?cancer_study_list=ucec_tcga_pan_can_atlas_2018&gene_list=KRAS%0ANRAS&case_set_id=ucec_tcga_pan_can_atlas_2018_all","url":"https://www.cbioportal.org/results/mutations?cancer_study_list=ucec_tcga_pan_can_atlas_2018&gene_list=KRAS%0ANRAS&case_set_id=ucec_tcga_pan_can_atlas_2018_all","data":{"studyIds":["ucec_tcga_pan_can_atlas_2018"],"studies":[{"studyId":"ucec_tcga_pan_can_atlas_2018","name":"Uterine Corpus Endometrial Carcinoma (TCGA, PanCancer Atlas)","sampleCount":529}],"genes":["KRAS","NRAS"],"caseSetId":"ucec_tcga_pan_can_atlas_2018_all","pageDescription":"Detailed mutation table with lollipop plot showing mutation positions, types, and frequencies for queried genes."}}

═ answer (success)
## Results

**Co-occurring KRAS and NRAS mutations in endometrial cancer: 0.8%**

In the TCGA PanCancer Atlas endometrial carcinoma cohort (529 patients), **4 patients (0.8%)** have co-occurring mutations in both KRAS and NRAS.

### Context

| Gene | Mutant Patients | Frequency |
|------|---|---|
| **KRAS** | 99 / 529 | 18.7% |
| **NRAS** | 21 / 529 | 4.0% |
| **Both (co-occurring)** | 4 / 529 | **0.8%** |

### Details of Co-Occurring Cases

The 4 patients with both mutations carry:

1. **TCGA-A5-A0G2**: KRAS Q61H (Missense) + NRAS D47N (Missense) + NRAS F78S (Missense)
2. **TCGA-AX-A0J0**: KRAS K176Q (Missense) + NRAS E162* (Nonsense)
3. **TCGA-B5-A0JV**: KRAS G12D (Missense) + NRAS Q61K (Missense)
4. **TCGA-DF-A2KZ**: KRAS A146V (Missense) + NRAS Q61R (Missense)

### Explore Further

- [View KRAS + NRAS mutant cohort overview](https://www.cbioportal.org/study/summary?id=ucec_tcga_pan_can_atlas_2018#filterJson=%7B%22geneFilters%22%3A%5B%7B%22geneQueries%22%3A%5B%5B%7B%22hugoGeneSymbol%22%3A%22KRAS%22%7D%2C%7B%22hugoGeneSymbol%22%3A%22NRAS%22%7D%5D%5D%2C%22molecularProfileIds%22%3A%5B%22ucec_tcga_pan_can_atlas_2018_mutations%22%5D%7D%5D%7D) — Study summary filtered to KRAS or NRAS mutant patients
- [View Mutations tab](https://www.cbioportal.org/results/mutations?cancer_study_list=ucec_tcga_pan_can_atlas_2018&gene_list=KRAS%0ANRAS&case_set_id=ucec_tcga_pan_can_atlas_2018_all) — Detailed mutation table and lollipop plots

**Important note:** This analysis reports all mutations regardless of functional impact. The query does not filter for "oncogenic" status — you may want to cross-reference these variants with OncoKB or other cancer variant databases to assess their functional significance.